SMS Pharmaceuticals Limited has officially received the coveted EDQM certification, a milestone that positions the Indian-based pharmaceutical giant to supply Ibuprofen to European markets. The European Directorate for the Quality of Medicines & HealthCare (EDQM) awarded this certification following a rigorous inspection of SMS Pharma’s Visakhapatnam facility. Conducted between February 28th and March 1st, 2024, […]
SMS Pharmaceuticals Limited said that it has secured certificate of suitability (CEP) approval from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for Ibuprofen. The approval will allow the Indian pharmaceutical company to launch sales of Ibuprofen in the European markets. P. Vamsi Krishna — SMS Pharmaceuticals Executive Director said: “We are […]
SMS Pharmaceuticals has secured a non‐exclusive license via the Medicines Patent Pool (MPP) for manufacturing nirmatrelvir, an oral antiviral Covid‐19 drug developed by Pfizer, to increase wider access to treatment in 95 low‐ and middle‐ income countries. Previously, Pfizer had announced that the clinical trial of PAXLOVID (nirmatrelvir tablets and ritonavir tablets) demonstrated significant reduction […]
